Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Strati

Showing results (51-60 of 139) with videos related to

Pageof 14
Sort By:
Leukemia & Lymphoma|December 17, 2020
Expression of BCL2 alternative proteins and association with outcome in CLL patients treated with venetoclaxMario L Marques-Piubelli, Ellen J Schlette, Joseph D Khoury, et al.
Annals of Hematology|March 2, 2017
Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractionsPaolo Strati, Prithviraj Bose, Lindsey Lyle, et al.
Cancer|October 24, 2013
HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemiaPaolo Strati, Hagop Kantarjian, Deborah Thomas, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 24, 2013
Biological and clinical features of trisomy 21 in adult patients with acute myeloid leukemiaPaolo Strati, Naval Daver, Farhad Ravandi, et al.
Therapeutic Advances in Medical Oncology|February 18, 2026
Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapyAndrew G Kuang, Malek Shatila, Jay S Shah, et al.
Cancer Cell|September 22, 2023
A single-cell atlas of CD19 chimeric antigen receptor T cellsXubin Li, Jared Henderson, Max J Gordon, et al.
Haematologica|March 19, 2026
Salvage high-dose chemotherapy and autologous stem cell transplant consolidation following relapse after CAR-T cell for large B-cell lymphomaJeremy Ramdial, Erica Agbadiba, Misha Hawkins, et al.
American Journal of Hematology|December 23, 2014
Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndromePaolo Strati, Hagop Kantarjian, Farhad Ravandi, et al.
British Journal of Haematology|April 8, 2017
CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemiaPaolo Strati, Sameer A Parikh, Kari G Chaffee, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2024
Gastrointestinal toxicities of proteasome inhibitor therapyJay Shah, Samanthika Devalaraju, Elliot Baerman, et al.
Pageof 14

Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
Leukemia & Lymphoma|December 17, 2020
Expression of BCL2 alternative proteins and association with outcome in CLL patients treated with venetoclaxMario L Marques-Piubelli, Ellen J Schlette, Joseph D Khoury, et al.
Annals of Hematology|March 2, 2017
Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractionsPaolo Strati, Prithviraj Bose, Lindsey Lyle, et al.
Cancer|October 24, 2013
HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemiaPaolo Strati, Hagop Kantarjian, Deborah Thomas, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 24, 2013
Biological and clinical features of trisomy 21 in adult patients with acute myeloid leukemiaPaolo Strati, Naval Daver, Farhad Ravandi, et al.
Therapeutic Advances in Medical Oncology|February 18, 2026
Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapyAndrew G Kuang, Malek Shatila, Jay S Shah, et al.
Cancer Cell|September 22, 2023
A single-cell atlas of CD19 chimeric antigen receptor T cellsXubin Li, Jared Henderson, Max J Gordon, et al.
Haematologica|March 19, 2026
Salvage high-dose chemotherapy and autologous stem cell transplant consolidation following relapse after CAR-T cell for large B-cell lymphomaJeremy Ramdial, Erica Agbadiba, Misha Hawkins, et al.
American Journal of Hematology|December 23, 2014
Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndromePaolo Strati, Hagop Kantarjian, Farhad Ravandi, et al.
British Journal of Haematology|April 8, 2017
CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemiaPaolo Strati, Sameer A Parikh, Kari G Chaffee, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2024
Gastrointestinal toxicities of proteasome inhibitor therapyJay Shah, Samanthika Devalaraju, Elliot Baerman, et al.
Pageof 14